ENDRA Life Sciences Files Q1 2025 10-Q

Ticker: NDRA · Form: 10-Q · Filed: May 15, 2025 · CIK: 1681682

Endra Life Sciences INC. 10-Q Filing Summary
FieldDetail
CompanyEndra Life Sciences INC. (NDRA)
Form Type10-Q
Filed DateMay 15, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

TL;DR

ENDRA Life Sciences Q1 2025 10-Q filed: Assets $25.2M, Liabilities $3M. Operations continue.

AI Summary

ENDRA Life Sciences Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $25,251,790 and total liabilities of $3,000,000. During the quarter, ENDRA continued its operations in the electromedical and electrotherapeutic apparatus sector, with its principal executive offices located in Ann Arbor, Michigan.

Why It Matters

This filing provides a snapshot of ENDRA Life Sciences' financial health and operational status as of the first quarter of 2025, crucial for investors assessing the company's performance.

Risk Assessment

Risk Level: medium — The company operates in a specialized sector and its financial figures, while providing a snapshot, do not inherently indicate significant growth or stability without further context on revenue and profitability.

Key Numbers

Key Players & Entities

FAQ

What were ENDRA Life Sciences' total assets as of March 31, 2025?

Total assets were $25,251,790 as of March 31, 2025.

What were ENDRA Life Sciences' total liabilities as of March 31, 2025?

Total liabilities were $3,000,000 as of March 31, 2025.

What is the principal business address for ENDRA Life Sciences Inc.?

The principal business address is 3600 GREEN COURT SUITE 350, ANN ARBOR, MI 48105.

What is the SIC code for ENDRA Life Sciences Inc.?

The SIC code is 3845, for ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

When was this 10-Q filing submitted?

This 10-Q filing was submitted on May 15, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding ENDRA Life Sciences Inc. (NDRA).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing